Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

PURPOSE: Preoperative aromatase inhibitor (AI) treatment promotes breast-conserving surgery (BCS) for estrogen receptor (ER) –positive breast cancer. To study this treatment option, responses to three AIs were compared in a randomized phase II neoadjuvant trial designed to select agents for phase II...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Ellis, Matthew J., Suman, Vera J., Hoog, Jeremy, Lin, Li, Snider, Jacqueline, Prat, Aleix, Parker, Joel S., Luo, Jingqin, DeSchryver, Katherine, Allred, D. Craig, Esserman, Laura J., Unzeitig, Gary W., Margenthaler, Julie, Babiera, Gildy V., Marcom, P. Kelly, Guenther, Joseph M., Watson, Mark A., Leitch, Marilyn, Hunt, Kelly, Olson, John A.
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Clinical Oncology 2011
Ábhair:
Original Reports
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107749/
https://ncbi.nlm.nih.gov/pubmed/21555689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.6950
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla